Vivanza Biosciences consolidated net profit declines 34.62% in the September 2022 quarter
Sales decline 51.96% to Rs 1.35 crore
Net profit of Vivanza Biosciences declined 34.62% to Rs 0.17 crore in the quarter ended September 2022 as against Rs 0.26 crore during the previous quarter ended September 2021. Sales declined 51.96% to Rs 1.35 crore in the quarter ended September 2022 as against Rs 2.81 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales1.352.81 -52 OPM %-2.221.42 -PBDT0.16-0.03 LP PBT0.16-0.03 LP NP0.170.26 -35Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 12 2022 | 8:16 AM IST